We are live on ! Find out more
ASTX

ASTEX PHARMACEUTICALS, INC COM
ASTX

Delisted

ASTX was delisted on the 10th of October, 2013.

Back to rankings

120 hedge funds and large institutions have $214M invested in ASTEX PHARMACEUTICALS, INC COM in 2013 Q2 according to their latest regulatory filings, with 120 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more call options, than puts

Call options by funds: $9.83M | Put options by funds: $9.7M

Holders
120
Holders Change
+120
Holders Change %
–
% of All Funds
3.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
120
Increased
–
Reduced
–
Closed
–
Calls
$9.83M
Puts
$9.7M
Net Calls
+$126K
Net Calls Change
+$126K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$1.82M +$2.38M +442,201 New
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$1.75M +$2.28M +424,897 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$1.69M +$2.21M +411,648 New
HCM
29
Highbridge Capital Management
New York
$1.68M +$2.2M +409,760 New
CCP
30
Centaur Capital Partners
Texas
$1.52M +$1.99M +370,000 New
SFM
31
Systematic Financial Management
New Jersey
$1.46M +$1.92M +356,219 New
Charles Schwab
32
Charles Schwab
California
$1.39M +$1.71M +318,409 New
BIM
33
BlackRock Investment Management
Delaware
$1.31M +$1.72M +319,171 New
Group One Trading
34
Group One Trading
Illinois
$1.3M +$1.7M +316,262 New
DCM
35
Driehaus Capital Management
Illinois
$1.22M +$1.6M +297,020 New
Connor, Clark & Lunn Investment Management (CC&L)
36
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.15M +$1.43M +265,500 New
Arrowstreet Capital
37
Arrowstreet Capital
Massachusetts
$1.12M +$1.46M +272,231 New
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$1.11M +$1.46M +270,700 New
SIM
39
Spark Investment Management
New York
$1.02M +$1.33M +247,900 New
Jane Street
40
Jane Street
New York
$1.01M +$1.32M +245,541 New
Jacobs Levy Equity Management
41
Jacobs Levy Equity Management
New Jersey
$982K +$1.28M +238,938 New
RFC
42
Russell Frank Company
Washington
$925K +$1.21M +225,130 New
CCMH
43
Cornerstone Capital Management Holdings
New York
$879K +$1.15M +213,463 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$860K +$1.12M +209,106 New
Two Sigma Investments
45
Two Sigma Investments
New York
$828K +$1.08M +201,292 New
OPCM
46
Osborne Partners Capital Management
California
$822K +$1.08M +200,000 New
UOC
47
UBS O'Connor
Illinois
$773K +$1.01M +188,000 New
Allianz Asset Management
48
Allianz Asset Management
Germany
$763K +$999K +185,700 New
CS
49
Credit Suisse
Switzerland
$754K +$986K +183,404 New
Barclays
50
Barclays
United Kingdom
$752K +$983K +182,886 New
1
2
3 4 5

ASTX Hedge Fund Activity: Q2 2013 in Review

120 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in ASTEX PHARMACEUTICALS, INC COM (ASTX) for Q2 2013, worth a combined $214M.

Buyers outnumbered sellers: 120 funds opened new ASTX positions and 0 closed out — a net gain of 120 holders — while 0 added to existing stakes and 0 trimmed.

  • 120 institutional investors held ASTEX PHARMACEUTICALS, INC COM (ASTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $214M of ASTEX PHARMACEUTICALS, INC COM stock for Q2 2013.
  • 120 funds opened new ASTEX PHARMACEUTICALS, INC COM positions in Q2 2013 and 0 closed out, a net change of +120 holders.

Based on aggregated 13F filings for Q2 2013.